Hongwen Qiao
Overview
Explore the profile of Hongwen Qiao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu L, Liu S, Chu M, Wang J, Xie K, Cui Y, et al.
NPJ Parkinsons Dis
. 2022 Oct;
8(1):128.
PMID: 36202819
The chromosome 9 open reading frame 72 (C9ORF72) has been proposed as the causative gene of frontotemporal dementia with parkinsonism (FTDP), but its pathophysiological mechanism of parkinsonism is poorly understood....
2.
Yao T, Qiao H, Sun J, Li X, Song Y, Xu F, et al.
Eur Neurol
. 2022 Jul;
85(6):467-477.
PMID: 35853433
Background: Spinocerebellar ataxia type 12 (SCA12) is a rare SCA subtype with unclear clinical and imaging features. Also, the radiological changes in prodromal and early stages remain unknown. Methods: Ten...
3.
Pan Y, Liu S, Zeng Y, Ye C, Qiao H, Song T, et al.
Front Aging Neurosci
. 2022 Jun;
14:902169.
PMID: 35769601
Objectives: [18F]9-fluoropropyl-(+)-dihydrotetrabenazine ([18F]-FP-DTBZ) positron emission tomography (PET) provides reliable information for the diagnosis of Parkinson's disease (PD). In this study, we proposed a multi-atlas-based [18F]-FP-DTBZ PET image segmentation method for...
4.
Kong Y, Xie K, Qiao H, Cui Y, Jing D, Wang Y, et al.
Front Neurol
. 2020 Dec;
11:566667.
PMID: 33363503
Posterior cortical atrophy (PCA) is widely considered as an atypical variant of Alzheimer disease and is characterized by a progressive decline in visual function. PCA has been investigated from the...
5.
Ji S, Wang C, Qiao H, Gu Z, Gan-Or Z, Fon E, et al.
Mov Disord
. 2020 Jan;
35(4):672-678.
PMID: 31912918
Background: Heterozygous mutations in the glucocerebrosidase gene (GBA) have been shown to be an important genetic risk factor for Parkinson's disease (PD) worldwide. However, the penetrance of GBA heterozygote for...
6.
Shi X, Zhang Y, Xu S, Kung H, Qiao H, Jiang L, et al.
Clin Nucl Med
. 2019 Jun;
44(9):707-713.
PMID: 31205154
Objective: Nonmotor symptoms (NMS) are critical players in the patients' quality of life in Parkinson disease (PD). Vesicular monoamine transporter type 2 (VMAT2) has been reported owing to a role...
7.
Liu J, Wang Q, Jing D, Gao R, Zhang J, Cui C, et al.
J Alzheimers Dis
. 2019 Mar;
68(2):551-558.
PMID: 30814350
For early-onset Alzheimer's disease (EOAD) cases with unclear family history, most cases are sporadic. Some cases are positive in genetic findings, that is, either incomplete penetrance or de novo mutation....
8.
Qiao H, Zhang Y, Wu Z, Zhu L, Choi S, Ploessl K, et al.
Nucl Med Biol
. 2016 May;
43(8):470-7.
PMID: 27236282
Serotonin transporters (SERT) in the brain play an important role in normal brain function. Selective serotonin reuptake inhibitors such as fluoxetine, sertraline, paroxetine, escitalopram, etc., specifically target SERT binding in...
9.
Zhu L, Li G, Choi S, Plossl K, Chan P, Qiao H, et al.
Nucl Med Biol
. 2013 Sep;
40(8):974-9.
PMID: 24035549
Introduction: In vivo positron emission tomography (PET) imaging of the serotonin transporter (SERT) is a valuable tool in drug development and in monitoring brain diseases with altered serotonergic function. We...
10.
Zhu L, Qiao H, Lieberman B, Wu J, Liu Y, Pan Z, et al.
Nucl Med Biol
. 2012 Jul;
39(7):897-904.
PMID: 22749185
Objectives: Recently, 9-[(18)F]fluoropropyl-(+)-dihydrotetrabenazine ((18)F-AV-133) was reported as a new vesicular monoamine transporter (VMAT2) imaging agent for diagnosis of Parkinson's disease (PD). To shorten the preparation of (18)F-AV-133 and to make...